Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pacific Hospital Supply CoROCO:4126 -1.15%83 EBITDA Margin % is 24.77% as of Dec. 2025, which is 13% below its 10-year median of 28.41. GuruFocus rates ROCO:4126 with a GF Score™ of 83/100 and a GF Value™ of NT$93.39 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Pacific Hospital Supply Co ranks better than 85.15% on this metric.
Pacific Hospital Supply Co (ROCO:4126) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Pacific Hospital Supply Co EBITDA Margin % Related Terms
Pacific Hospital Supply Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4126 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Pacific Hospital Supply Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pacific Hospital Supply Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pacific Hospital Supply Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Pacific Hospital Supply Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pacific Hospital Supply Co (ROCO:4126) has a EBITDA Margin % of 24.77% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Pacific Hospital Supply Co and its competitors. This is 13% below median its historical median of 28.41. Over the past decade, Pacific Hospital Supply Co's EBITDA Margin % has ranged from 23.81 to 35.01. According to the industry distribution chart, Pacific Hospital Supply Co ranks #121 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 14.8%.
Is Pacific Hospital Supply Co's EBITDA Margin % too high?
Pacific Hospital Supply Co's current EBITDA Margin % of 24.77% is 13% below median its 10-year median of 28.41. Over the past 10 years, this metric has ranged from a low of 23.81 to a high of 35.01. The Medical Devices & Instruments industry median EBITDA Margin % is 7.47. Pacific Hospital Supply Co's value of 24.77% is 231.6% above this industry median. Based on the distribution chart, Pacific Hospital Supply Co ranks #121 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Pacific Hospital Supply Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pacific Hospital Supply Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Pacific Hospital Supply Co ranks #121 out of 815 companies for EBITDA Margin %. This places Pacific Hospital Supply Co in the top 15% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.47. Pacific Hospital Supply Co's value of 24.77% is 231.6% above this benchmark. Historically, Pacific Hospital Supply Co's own EBITDA Margin % has ranged from 23.81 to 35.01 over the past decade. While the company's 10-year median is 28.41 vs. the industry median of 7.47, Pacific Hospital Supply Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.47, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pacific Hospital Supply Co's current EBITDA Margin % of 24.77% is 231.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Pacific Hospital Supply Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pacific Hospital Supply Co's current EBITDA Margin % is 24.77%, which is 13% below median its own 10-year median of 28.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Hospital Supply Co stock overvalued right now?
Based on GuruFocus' analysis, Pacific Hospital Supply Co (ROCO:4126) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$93.39, compared to a current price of NT$77.30 — trading 17.2% below its estimated fair value. The current EBITDA Margin % is 24.77%, which is 13% below median its 10-year median of 28.41 and 231.6% above the Medical Devices & Instruments industry median of 7.47. Pacific Hospital Supply Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Pacific Hospital Supply Co (ROCO:4126), the current EBITDA Margin % is 24.77% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pacific Hospital Supply Co (ROCO:4126) Overvalued in 2026?
Based on GuruFocus' analysis, Pacific Hospital Supply Co stock appears to be undervalued.
The current stock price of NT$77.30 is trading 17.2% below its estimated GF Value™ of NT$93.39.
GuruFocus considers Pacific Hospital Supply Co to be Modestly Undervalued.
Key valuation signals for ROCO:4126:
EBITDA Margin %: 24.77% (13% below median its 10-year median of 28.41)
GF Value™: NT$93.39 vs. price of NT$77.30 (17.2% below fair value)
Industry Position: 231.6% above the Medical Devices & Instruments median (#121 of 815)
No single metric tells the full story. See the ROCO:4126 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pacific Hospital Supply Co Ltd mainly manufactures, processes, and sells medical disposable products and equipment and does medical engineering work on centralized medical gas piping systems.
83GF Score
Get the complete analysis for ROCO:4126
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4126 has been successfully added to your 
